author-photo

Nathalie A. Brophy

Stanford University

13

Papers

1535

Citations

Citation Trend

Filter By

Papers (12) Sort By

Journal Conference Others

Mitoxantrone, Etoposide, and Cyclosporine Therapy in Pediatric Patients With Recurrent or Refractory Acute Myeloid Leukemia

2000 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (46)
Mitoxantrone, Etoposide and Cyclosporine A Therapy for Relapsed and Refractory Acute Myelogenous Leukemia, A Pediatric Oncology Group Phase II Trial

1996
Show All
- Source
- Cite
- Save
Citations (0)
Methods to detect P-glycoprotein-associated multidrug resistance in patients' tumors: Consensus recommendations

1996 Cancer Research
Show All
- Source
- Cite
- Save
Citations (382)
The effect of oral SDZ PSC 833 on the pharmacokinetics (PK) of etoposide (E) during a phase I trial to modulate multidrug resistance: 102

1994 Anti-Cancer Drugs
Show All
- Source
- Cite
- Save
Citations (2)
A phase I study of paclitaxel (taxol®) (T) in combination with SDZ PSC 833, a potent modulator of multidrug resistance (MDR): 99

1994 Anti-Cancer Drugs
Show All
- Source
- Cite
- Save
Citations (4)
Phase I trial of doxorubicin with cyclosporine as a modulator of multidrug resistance.

1994 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (173)
Mdr1 gene expression in childhood acute lymphoblastic leukemias and lymphomas: a critical evaluation by four techniques.

1994 Leukemia
Show All
- Source
- Cite
- Save
Citations (62)
Clinical reversal of multidrug resistance.

1994 Cancer treatment and research
Show All
- Source
- Cite
- Save
Citations (10)
Clinical trials of modulation of multidrug resistance pharmacokinetic and pharmacodynamic considerations

1993 Cancer
Show All
- Source
- Cite
- Save
Citations (135)
Phase I trial of etoposide with cyclosporine as a modulator of multidrug resistance.

1992 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (207)